New multiplex panel can detect SARS CoV 2, Flu A Flu B RSV at the Point of Need and can deliver accurate PCR results in approximately 30 minutes.

BIVDA welcomes the In Vitro Diagnostic Medical Devices Regulation and urges continued work to deploy the new regulatory system.

Researchers at the University of Swansea have developed a blood test that utilises Artificial Intelligence to identify patterns of cancer leaked into the bloodstream.

This new hub will support nearly 10,000 manufacturers and is an opportunity for SMEs to better utilise their data.

Health and Social Care Committee Chair Jeremy Hunt has criticised the Government for the move.

We welcome the reiteration of Government announcements to boost diagnostic capacity through Community Diagnostic Centres (CDCs) and increased, more efficient testing.

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has chosen it to supply biosamples for the Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD) Project.

Potential UK draft legislation to scrap the Protocol has been reported in the media. The EU has called for honesty and a climb-down in rhetoric on the issue.

The adjournment debate secured by Neale Hanvey MP followed discussion in the Main Chamber about the Queen’s Speech and covered the UK diagnostics industry’s experience of the pandemic and what can be learned in future.

A total of 38 draft Bills and Bills are on the agenda in the upcoming Government session, including the important Procurement Bill.